Skip to main content
. Author manuscript; available in PMC: 2018 Nov 1.
Published in final edited form as: Am J Transplant. 2017 Aug 14;17(11):2945–2954. doi: 10.1111/ajt.14415

Figure 1. Study design and subject schedule of events.

Figure 1

Blood for Treg manufacturing was drawn at day −14, and Treg infusion was given on day 0. Subjects were seen for follow-up assessments on day 4, 7, 14 and 28, and at months 3, 6 and 12. Laboratory assessments were done weekly after the first week, and monthly after the first month.